Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients (Q28730798)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 2012)

Language	Label	Description	Also known as
English	Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients	scientific article (publication date: 2012)

Statements

scholarly article

0 references

Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients (English)

0 references

0 references

Robert M. Prins

object named as

Robert M Prins

9

0 references

object named as

Isaac Yang

6

0 references

author name string

Brendan Fong

1

0 references

Richard Jin

2

0 references

Xiaoyan Wang

3

0 references

Michael Safaee

4

0 references

Dominique N Lisiero

5

0 references

Gang Li

7

0 references

Linda M Liau

8

0 references

language of work or name

0 references

publication date

2012

0 references

0 references

7

0 references

4

0 references

e32614

0 references

copyright license

Creative Commons Attribution 4.0 International

2 April 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

17 March 2017

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

17 March 2017

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

17 March 2017

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

17 March 2017

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

7 April 2017

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 T reg cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

7 April 2017

Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Cytotoxic T-Lymphocyte–Associated Antigen-4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

CTLA-4 blockade increases antigen-specific CD8( ) T cells in prevaccinated patients with melanoma: three cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Single dose of anti-CTLA-4 enhances CD8 T-cell memory formation, function, and maintenance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Induction of CD8 T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

An increase in CD4 CD25 FOXP3 regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Malignant gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

Brain tumor survival: results from the National Cancer Data Base

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

3 June 2018

PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12.

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

Prolongation of survival following depletion of CD4 CD25 regulatory T cells in mice with experimental brain tumors

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

CD4 CD25 FoxP3 T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

CD4 FoxP3 regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4 T cell compartment without affecting regulatory T-cell function

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0032614

21 January 2018

Treatment of newly diagnosed glioblastoma multiforme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

27 November 2018

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317661

27 November 2018

Ipilimumab approved for metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22485134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0032614

0 references

2012PLoSO...732614F

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28730798&oldid=1867920545"